Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $656.7 billion, total revenue of $168.66 billion and a weighted average PE ratio of 36.93.
Market Cap
656.7B
Revenue
168.66B
Profits
17.78B
PE Ratio
36.93
Profit Margin
10.54%
Dividend Yield
0.24%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 175.76B | 1.33% | 1,861,540 | 45.20B |
| 2 | DHR | Danaher Corporation | 123.80B | 0.17% | 5,983,307 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.69B | 2.89% | 665,238 | 4.45B |
| 4 | WAT | Waters Corporation | 34.31B | 1.98% | 1,864,888 | 3.77B |
| 5 | A | Agilent Technologies, Inc. | 33.26B | 0.14% | 2,734,585 | 7.07B |
| 6 | NTRA | Natera, Inc. | 30.71B | 4.02% | 2,136,394 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 29.45B | 0.03% | 1,837,407 | 16.63B |
| 8 | MTD | Mettler-Toledo International Inc. | 26.87B | 1.89% | 183,286 | 4.03B |
| 9 | ILMN | Illumina, Inc. | 21.57B | 2.52% | 1,332,064 | 4.39B |
| 10 | LH | Labcorp Holdings Inc. | 21.07B | -0.08% | 1,066,263 | 14.14B |
| 11 | DGX | Quest Diagnostics Incorporated | 20.94B | -0.90% | 898,644 | 11.28B |
| 12 | MEDP | Medpace Holdings, Inc. | 12.19B | -0.82% | 356,511 | 2.68B |
| 13 | GH | Guardant Health, Inc. | 12.10B | 3.05% | 1,682,903 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 11.08B | 7.36% | 3,014,202 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 9.48B | 2.32% | 1,230,810 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.97B | -1.97% | 1,102,518 | 4.02B |
| 17 | QGEN | Qiagen N.V. | 7.12B | 1.29% | 1,643,979 | 2.09B |
| 18 | RDNT | RadNet, Inc. | 4.59B | -0.64% | 711,853 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.51B | 3.07% | 4,404,922 | 1.19B |
| 20 | BLLN | BillionToOne, Inc. | 3.74B | 1.88% | 717,201 | 354.54M |
| 21 | TWST | Twist Bioscience Corporation | 3.71B | 4.99% | 1,446,281 | 409.48M |
| 22 | VCYT | Veracyte, Inc. | 3.29B | 24.93% | 2,994,423 | 541.74M |
| 23 | GRAL | GRAIL, Inc. | 2.69B | 15.35% | 1,257,432 | 156.12M |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 2.31B | 4.72% | 4,900,345 | 295.41M |
| 25 | NEO | NeoGenomics, Inc. | 1.16B | 0.34% | 1,694,876 | 745.97M |
| 26 | CDNA | CareDx, Inc. | 1.08B | 1.21% | 568,705 | 412.82M |
| 27 | WGS | GeneDx Holdings Corp. | 1.03B | 0.58% | 4,265,237 | 442.68M |
| 28 | OPK | OPKO Health, Inc. | 845.70M | -0.88% | 1,711,257 | 581.12M |
| 29 | CSTL | Castle Biosciences, Inc. | 749.83M | 0.61% | 701,839 | 339.92M |
| 30 | PSNL | Personalis, Inc. | 635.39M | 9.17% | 3,173,355 | 69.65M |
| 31 | FLGT | Fulgent Genetics, Inc. | 423.74M | 0.13% | 706,462 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 388.16M | -18.29% | 7,460,240 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 267.57M | -4.96% | 261,512 | 92.39M |
| 34 | BNR | Burning Rock Biotech Limited | 179.39M | -0.12% | 3,590 | 77.14M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 161.80M | 9.83% | 653,456 | 4.06M |
| 36 | BDSX | Biodesix, Inc. | 151.61M | 0.40% | 108,831 | 96.10M |
| 37 | FONR | FONAR Corporation | 123.77M | -0.11% | 20,539 | 106.03M |
| 38 | MDXH | MDxHealth SA | 103.76M | 1.00% | 212,495 | 107.88M |
| 39 | XGN | Exagen Inc. | 74.60M | - | 251,409 | 66.58M |
| 40 | PRPO | Precipio, Inc. | 53.51M | -7.38% | 34,388 | 24.05M |
| 41 | MBAI | Check-Cap Ltd. | 10.42M | - | 11,607 | - |
| 42 | NOTV | Inotiv, Inc. | 10.30M | -5.64% | 407,790 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 10.07M | -4.51% | 84,282 | 29.21M |
| 44 | ADVB | Advanced Biomed Inc. | 9.25M | -1.17% | 86,898 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 8.90M | -1.98% | 430,015 | 6.16M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.03M | 0.21% | 8,625 | - |
| 47 | QUCY | Quantum Cyber N.V. | 4.75M | 4.37% | 169,047 | 537.08K |
| 48 | ISPC | iSpecimen Inc. | 4.32M | -1.85% | 236,319 | 1.93M |